EUVIMEDEUVIMED entdecken
Open Access

Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer

Yuka Nagashima, Megumi Ogino, Ranman Okiyama, Ryosuke Chiwaki, Hayato Ishii, Kana Nohata, Ayaka Nakahara, Ayaka Ozaki, Takahiro Kasai, Shoma Tamori, Shigeo Ohno, Kazunori Sasaki und 1 weitere

Cancer Genomics - Proteomics · 2026-03 · 23 (2) · 322-341

DOI: 10.21873/cgp.20579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 01.03.2026. Verfasst von Yuka Nagashima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Protein Kinase C, Aldehyde Oxidoreductases. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProtein Kinase CAldehyde OxidoreductasesHumansFemaleProtein Kinase C zetaPrognosisGene Expression Regulation, NeoplasticBiomarkers, TumorNeoplastic Stem Cells

Stichwörter der Autor:innen

ALDH1A3Basal-like breast cancerPKCζchemotherapy

Substanzen

Protein Kinase Caldehyde dehydrogenase (NAD(P)+)Aldehyde OxidoreductasesProtein Kinase C zetaBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
  • Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan.
  • Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan; akimoto@rs.tus.ac.jp k.sasaki.yb@juntendo.ac.jp.
  • Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan; akimoto@rs.tus.ac.jp k.sasaki.yb@juntendo.ac.jp.

Zitieren

APA

Nagashima, Y., Ogino, M., Okiyama, R., Chiwaki, R., Ishii, H., Nohata, K., Nakahara, A., Ozaki, A., Kasai, T., Tamori, S., Ohno, S., Sasaki, K., & Akimoto, K. (2026). Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer. Cancer Genomics - Proteomics, 23(2), 322-341. https://doi.org/10.21873/cgp.20579

Vancouver

Nagashima Y, Ogino M, Okiyama R, Chiwaki R, Ishii H, Nohata K, et al. Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer. Cancer Genomics - Proteomics. 2026;23(2):322-341. doi:10.21873/cgp.20579

BibTeX
@article{Nagashima2026,
  author = {Nagashima, Yuka and Ogino, Megumi and Okiyama, Ranman and Chiwaki, Ryosuke and Ishii, Hayato and Nohata, Kana and Nakahara, Ayaka and Ozaki, Ayaka and Kasai, Takahiro and Tamori, Shoma and Ohno, Shigeo and Sasaki, Kazunori and Akimoto, Kazunori},
  title = {Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer},
  journal = {Cancer Genomics - Proteomics},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {322--341},
  doi = {10.21873/cgp.20579}
}
Kostenlos starten →